Drostronate 100 Kosher Pharma INT

Product Overview

Drostronate 100 Kosher Pharma INT is an injectable anabolic‑androgenic steroid supplied as 100 mg/ml Drostanolone in sealed ampoules, typically packaged in wallets of multiple 1 ml units. The product is positioned for knowledgeable adult consumers, research use, and collection in jurisdictions where such compounds may be handled within a regulated framework. As a DHT‑derived agent, Drostronate 100 is often selected by buyers already familiar with “dry” or non‑aromatizing compound profiles, while still requiring clear, compliant, non‑therapeutic product communication.

Brand & Manufacturer Information

Kosher Pharma is presented in the market as a specialist manufacturer of injectable anabolic formulations, with a catalogue that includes various testosterone esters, trenbolone esters, boldenone, nandrolone, methenolone, and drostanolone products. The brand’s offerings are typically positioned as export‑oriented, serving clinics, wholesalers, and performance‑focused markets via international distribution partners. Packaging, naming conventions, and repeated product lines (such as Drostronate, Decanate, Primanex) support brand recognition and help buyers distinguish Kosher Pharma items from other manufacturers in multi‑brand storefronts.

Active Compound Information

Drostronate 100 contains Drostanolone, a dihydrotestosterone (DHT)‑derived anabolic‑androgenic steroid. Depending on the specific presentation, it is marketed either as Drostanolone Propionate or Drostanolone Enanthate at 100 mg/ml; both are non‑aromatizing DHT derivatives but differ in ester and release profile. As a DHT‑based agent, Drostanolone is classed as a moderate‑anabolic, androgenic compound that does not convert to estrogen, which is why it historically appeared in certain oncology protocols and in physique‑oriented contexts. No outcome, benefit, or performance effect is guaranteed, and no medical or enhancement claims should be inferred from the compound classification alone.

Product Specifications

Drostronate 100 Kosher Pharma INT is typically supplied as:

• Active ingredient: Drostanolone (Propionate or Enanthate, depending on label)

• Strength: 100 mg/ml

• Presentation: 1 ml glass ampoules, often in wallets containing multiple ampoules

• Form: Oil‑based injectable solution for intramuscular use

• Packaging details: Each ampoule is clear or lightly tinted glass with scored neck and printed product name, strength, and manufacturer identification.
  The 100 mg/ml concentration is a common standard for drostanolone injectables, allowing straightforward volume calculation for inventory and research planning.

Quality Control & Testing Standards

Kosher Pharma markets Drostronate 100 as a sterile injectable product, manufactured under controlled conditions with attention to active ingredient assay, particulate inspection, and fill‑volume consistency. While it is not a branded, regulator‑approved retail pharmaceutical in most consumer markets, the product is presented as batch‑coded with traceable lot and expiry information on both ampoule and outer packaging. Buyers in the research and performance space typically rely on this coding, vendor reputation, and any third‑party assay data that distributors may choose to publish, rather than on formal public regulatory dossiers.

Intended Use & Market Positioning

Drostronate 100 Kosher Pharma INT is intended for:

• Informed adult consumers in research, reference, and collection contexts.

• Markets where controlled‑substance handling is clearly regulated and users are expected to understand relevant legal obligations.
  Positioning focuses on its role as a DHT‑based injectable option within broader stacks or compound libraries, not as an introductory product for inexperienced users. Communication around the product avoids prescriptive use instructions and instead emphasizes that any handling or application must follow applicable laws and professional guidance.

Packaging, Storage & Handling

Drostronate 100 ampoules are usually supplied in cardboard wallets or trays, with internal separators to protect glass during transport. Ampoules are sealed at the neck and may include color rings or score lines to support safe snapping with appropriate ampoule‑opening technique. For integrity, storage should be in a cool, dry place at controlled room temperature, away from direct light and extremes of heat or cold, according to standard injectable oil handling practice. Handling must remain clean and careful to avoid ampoule breakage and contamination, with opened units used immediately and never stored for later reuse.

Purchasing & Availability Information

In practice, Drostronate 100 Kosher Pharma INT appears in the catalogues of international performance‑oriented eCommerce retailers and research‑chemical distributors. These channels typically highlight:

• Secure online checkout using card, transfer, or cryptocurrency options.

• Discreet packaging and tracking where permitted.

• Indication of origin (INT) and estimated delivery windows by region.
  Stocks and batch numbers may change over time, so buyers generally check live availability and country‑specific shipping terms before placing orders.

Legal & Regulatory Disclaimer

Drostronate 100 Kosher Pharma INT contains an anabolic‑androgenic steroid active ingredient that is controlled or prescription‑only in many jurisdictions. Responsibility for lawful purchase, import, possession, and any use lies solely with the buyer, who must verify and comply with all applicable local, regional, and national regulations. The product is offered only for lawful research, reference, and collection purposes; no medical advice, diagnostic guidance, or therapeutic or performance guarantees are provided. It is not promoted for human or veterinary administration, and any non‑compliant use is entirely at the user’s own risk and subject to the laws of their jurisdiction.